Transplantation Market Size To Rake USD 33.7 Bn By 2032

Published Date : 04 Aug 2023

The global transplantation market size surpassed USD 15.1 billion in 2022 and it is expected to rake around USD 33.7 billion by 2032, poised to grow at a CAGR of 8.36% during the forecast period 2023 to 2032.

Transplantation Market Size and Growth Rate From 2023 To 2032

Market Overview:

The healthcare industry's expanding transplantation business is advancing with the increased incidence of chronic illnesses and trauma cases. The market for organ transplants is set to grow as knowledge of the donation of organs and registration rises. Global awareness about organ donation across the globe is anticipated to have a favorable impact on the transplantation industry. Government initiatives and support have also significantly contributed to the market's expansion. The difference between the donor and the receiver is still widening, putting pressure on the expanding market. The discrepancy between demand and supply is projected to narrow due to technological advancements and interdisciplinary research. Due to the intense competition in the industry, several firms are making significant R&D investments to provide innovative goods and services.

Regional Snapshot:

North America is leading the global transplantation market. The significant need for organ transplants and innovative tissue transplantation products is anticipated to keep the region's leadership position. Additional factors supporting the growth of the industry in the area include adequate reimbursement policies and the quick uptake of three-dimensional 3D bioprinting. A common contributing aspect to the market's robust expansion in North America is the presence of well-known corporations and regulatory approvals for novel goods.

On the other hand, Asia Pacific is expected to register the fastest rate of growth during the forecast period. Countries in Asia Pacific are investing in the development of transplantation centers with advanced medical care centers. The rising population in Asian countries is another factor to boost the demand for transplantation surgeries in the region. In addition, the presence of professional and advanced services from the developing healthcare infrastructure along with rising organ donation activities in the region promotes the expansion of the market.

Report Highlights:

  • By product, the immunosuppressive drugs segment is expected to register the fastest rate of growth during the forecast period. Immunosuppressive drugs ensure the recipient’s immune system doesn’t attack new organ, the ability of these drugs in boosting survival rates promotes the growth of the segment.
  • By application, the tissue transplantation segment is expected to grow at a significant rate during the forecast period. The segment dominates the market due to its broad applications across medical specialties, including orthopedics and cardiology.
  • By end-use, the hospitals segment held the largest share of the market in 2022, the segment is expected to sustain its position during the forecast period. The presence of advanced services for genetic testing and transplantation services.

Transplantation Market Report Scope:

Report Coverage Details
Market Revenue in 2023 USD 16.36 Billion
Projected Forecast Revenue in 2032 USD 33.7 Billion
Growth Rate from 2023 to 2032 CAGR of 8.36%
Largest Market North America
Base Year 2022
Forecast Period 2023 To 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics:


Advancements in medical sciences

Advancements in medical science result in increased rate of medical research, these research activities led to the development of more effective and targeted immunosuppressive drugs. These drugs help prevent organ rejection by suppressing the recipient’s immune response, improving the success rates of transplant surgeries. Research in tissue engineering and regenerative medicine is paving the way for creating artificial organs or growing organs from a patient’s own cells. While this field is still evolving, it holds the potential to overcome organ shortages in the future. Medical science has led to a better understanding of the risks associated with transplantation, allowing medical professionals to provide more informed care and reduce potential complications. Thus, advancements in medical science is considered to be a driver for the market.


Cost of transplantation

Transplantation procedures require highly skilled surgeons, medical teams and specialized facilities which can drive up labor and infrastructure costs. Patients undergoing organ transplantation need to take immunosuppressive medications for the rest of their lives to prevent organ rejection. These medications can be expensive and can add up to a significant long-term cost.

Transplant recipients require ongoing medical care, including regular check-ups, tests and monitoring. This ongoing care adds to the overall cost of transplantation. The process of evaluating a patient's suitability for transplantation involves various medical tests, imaging and consultations all of which contribute to the cost. Thus, the cost of transplantation hinders the growth of the market.


Growing awareness about organ donation

Greater awareness encourages individuals to register as organ donors. This is especially crucial given the shortage of organs for transplantation. The increased interest in organ donation can drive research and innovation in transplantation techniques, improving success rates and patient outcomes. Increased awareness often leads to collaborations between governmental bodies, healthcare organizations and non-profit organizations, which can collectively work towards improving transplantation infrastructure and processes. International organizations often support campaigns to raise awareness about organ donation, leading to improvements in healthcare policies and regulations related to transplantation. Thus, the factor is observed to present multiple opportunities for the market.


Organ shortages and risks of rejection

Despite immunosuppression, the body may still reject the transplanted organ. Finding the right balance of immunosuppressive medication is critical to prevent rejection while minimizing side effects. Moreover, the demand for organs often exceeds the available supply, leading to long waiting lists for patients in need of transplants. This shortage of organs is a significant challenge globally. Thus, organ shortages and risk of rejection are considered to pose a challenge for the market.

Recent Developments:

  • In October 2022, the US-based biotechnology startup Plexision started its international business by opening a reference lab in Hyderabad, India. This facility will provide transplant patients with a wide variety of diagnostics. These tests include medication level monitoring, pharmacogenomics, genetic testing, and the company's unique personalized transplant diagnostic assays to anticipate viral infections and rejection. The company's goods were displayed during the Indian Society for Organ Transplantation's annual conference in Nagpur, India, and were made accessible in the latter half of 2022.

Major Key Players:

  • Arthrex, Inc.
  • Abbvie, Inc.
  • Teva Pharmaceuticals
  • Medtronic PLC
  • Zimmer Biomet
  • Strykers
  • Novartis AG
  • BiolifeSolutions, Inc.
  • 21st Century Medicine
  • Veloxis Pharmaceutical

Market Segmentation:

By Product Type

  • Immunosuppressive Drugs
  • Tissue Products
  • Preservation Solution

By Application

  • Tissue Transplantation
  • Organ Transplantation

By End-use

  • Transplant Centers
  • Hospitals
  • Others

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 9197 992 333